Trade & Exports

The remedy war is now unmistakably multi-front and multi-country, and Beijing has moved from defense to offense on a strategically sensitive chip input. On 14 September the US initiated less-than-fair-value and countervailing-duty investigations into certain linear hydraulic cylinders from Canada, China, India, Korea and Mexico, and instituted parallel antidumping and countervailing-duty probes into corrugated pizza boxes from China, Malaysia and Turkey ^1,2,3. Two days earlier MOFCOM's preliminary ruling found dumping of dichlorosilane (二氯二氢硅, a chip-film deposition precursor) from Japan and imposed provisional cash-deposit duties from 8 September ⁴. The net is closing on third countries while Beijing opens its own front against a supplier of semiconductor materials — a genuine intensification, not routine upkeep.

The multi-country design of the new US cases is the point. Hydraulic cylinders pull Canada, India, Korea and Mexico into the same docket as China ^1,2; pizza boxes name Malaysia and Turkey alongside China ³. This is the trend the standing brief flagged — remedies that erase the neutrality of relay markets — now running through fresh investigations rather than the administrative reviews that dominated the last batch. When a case names China, Malaysia and Turkey together, an exporter in Penang or Izmir carries duty risk whether or not the goods originated in China, which is exactly the exposure that transshipment-heavy diversification is meant to avoid.

Beijing's own remedy docket now has a semiconductor edge. MOFCOM's Announcement No. 37 of 2026 found that Japanese dichlorosilane was dumped, that the domestic industry suffered material injury and that the two were causally linked, imposing provisional margins via customs deposits from 8 September ⁴. The original probe opened on 7 January 2026 under Announcement No. 2. Set beside the extended pecan case against Mexico and the United States, which now runs to 25 March 2027 ⁵, it shows MOFCOM will use trade remedies as counter-leverage on upstream materials, not only on farm goods. That raises the odds of reciprocal escalation with Tokyo specifically, in a sector where China is simultaneously a major importer of advanced inputs and a target of US export controls.

Against that, the diversification machinery keeps running through the fair circuit and physical corridors. Guangdong served as guest province at the 26th China International Investment and Trade Fair in Xiamen on 8 September, with Governor Meng Fanli pitching Guangdong as an investment magnet and framing the 15th Five-Year Plan (十五五) as an opening-up vehicle ⁶. Guizhou sent ten service-trade firms to the China International Fair for Trade in Services in Beijing on 9-13 September, an event drawing roughly 90 countries and regions ⁷, and Liaoning stages its 7th international investment and trade fair in Shenyang on 23-25 September with Mongolia as guest of honour and Korean and Russian participation ⁸. The southern corridor advances in parallel: the Yellow-Baise Railway, 312.34 km and now over half complete, is due in 2028 to give inland Guizhou a low-cost exit toward the Beibu Gulf and ASEAN via the Pinglu Canal ⁹.

Intellectual-property pressure is running alongside the trade-remedy stream. The US International Trade Commission issued a notice of receipt of a complaint and solicited public-interest comments ¹⁰, and declined to review an initial determination allowing Dolby Laboratories to intervene in the video-capable electronic devices case ¹¹. These steps are procedural, but they sit in the same lane as the tariff cases — another channel through which Chinese consumer-electronics exporters get pulled into US proceedings.

The limit worth watching is two-sided. Externally, third-country naming in the new investigations erodes the neutrality of the relay markets — ASEAN, Mexico, Turkey — that Beijing's diversification depends on. Internally, Beijing's willingness to impose provisional duties on Japanese chip inputs invites reciprocal action. The pecan case already showed MOFCOM will extend probes when cases are "complex" ⁵; the dichlorosilane ruling shows it will act early when it finds injury. Neither move buys tariff relief; both add counterparties who now have a reason to retaliate.

Net: the standing read is confirmed and sharpened. The US remedy net keeps widening to third countries through fresh multi-country investigations rather than administrative upkeep, while Beijing now wields its own remedies offensively on a semiconductor precursor against Japan. The diversification answer — corridors, trade fairs, coalition-building — continues, but the neutrality of the relay markets that make the whole strategy work is what is eroding fastest.